The Evolving Incretin-Based Therapeutic Landscape
Eli Lilly and Company |
Thursday
Alice Cheng (CAN) 22.09.2022 16:00 – 16:30 Networking Hub
Alice Cheng (CAN) 22.09.2022 16:00 – 16:30 Networking Hub
13:00 – 13:30 Suliqua Meet the Expert Katie Whitmire (USA)Rory McCrimmon (USA) 22.09.2022 13:00 – 13:30 Networking Hub
Chair: Tina Vilsbøll (DNK) 14:15 – 14:19 Welcome and introductions Tina Vilsbøll (DNK) 14:19 – 14:28 First phase 3 evidence for a once-weekly insulin Athena
Chair: Filip Knop (DNK) 11:45 – 11:50 Welcome and IntroductionOverview of semaglutide, PIONEER and SUSTAIN trials Filip Knop (DNK) 11:50 – 12:00 Case based discussions
10:00 – 10:30 Benefits and drawbacks of early effective intervention in T2DFollowed by discussion Partha Kar (UK)Kamlesh Khunti (UK) 22.09.2022 10:00 – 10:30 Networking Hub
